IRS

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Amgen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMGN

Retrieved on: 
Tuesday, March 21, 2023

WHAT TO DO NEXT: To join the Amgen class action, go to https://rosenlegal.com/submit-form/?case_id=13114 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Amgen class action, go to https://rosenlegal.com/submit-form/?case_id=13114 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amgen Inc. (AMGN)

Retrieved on: 
Tuesday, March 21, 2023

Investors suffering losses on their Amgen investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected] .

Key Points: 
  • Investors suffering losses on their Amgen investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected] .
  • On this news, Amgen’s stock price fell $15.77, or 6.5%, to close at $228.31 per share on August 4, 2021, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

OTC Markets Group Celebrates the Passing of ESOP Fairness Act Legislation

Retrieved on: 
Tuesday, March 21, 2023

NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc .

Key Points: 
  • NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc .
  • (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, celebrates the ESOP Fairness Act ( S.3270 ) ( H.R.5851 ), which was included in the SECURE Act 2.0 retirement package that was signed into law on December 29, 2022.
  • With approximately 800 OTCQX and OTCQB companies meeting the criteria under the ESOP Fairness Act, the OTC Markets Group team played an active role in advocating for this legislation on behalf of these companies and their many employees.
  • "The ESOP Fairness Act will make ESOPs more effective for hundreds of community banks and other small companies, and will benefit their many employees across the country.

Amgen Inc.: Please contact the Portnoy Law Firm to recover your losses; May 12, 2023 deadline.

Retrieved on: 
Monday, March 20, 2023

​LOS ANGELES, March 20, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Amgen Inc. (NASDAQ: AMGN) investors that a lawsuit filed on behalf of investors that purchased Amgen securities  (NASDAQ: AMGN)  between July 29, 2020 and April 27, 2022, inclusive (the “Class Period”).

Key Points: 
  • Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 844-767-8529 or email : [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com .
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The lawsuit claims that Amgen did not comply with accounting rules and regulations and was exposed to severe financial penalties from the IRS.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amgen Inc. - AMGN

Retrieved on: 
Monday, March 20, 2023

NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. (“Amgen” or the “Company”) (NASDAQ: AMGN).

Key Points: 
  • NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. (“Amgen” or the “Company”) (NASDAQ: AMGN).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Amgen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bronstein, Gewirtz & Grossman, LLC Notifies Amgen Inc. (AMGN) Investors of Class Action and to Actively Participate

Retrieved on: 
Monday, March 20, 2023

Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/amgn .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/amgn .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

IRS and Top Government Agencies to Discuss Taxes, Remote Employees, and Other Payroll Issues

Retrieved on: 
Monday, March 20, 2023

The two-day conference will be held at the Hilton Arlington National Landing Hotel in Arlington, VA, March 20 – 21.

Key Points: 
  • The two-day conference will be held at the Hilton Arlington National Landing Hotel in Arlington, VA, March 20 – 21.
  • "It is vital that payroll professionals remain up-to-date on the rapidly changing legislation impacting payroll," said Dan Maddux, executive director at the APA.
  • "Capital Summit brings together top government agency officials directly with payroll professionals to advise them on issues impacting payroll and employee paychecks."
  • The American Payroll Association (APA) is the nation's leader in payroll education, publications, and training.

AMGN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Amgen Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Lawsuit

Retrieved on: 
Monday, March 20, 2023

), the Amgen class action lawsuit charges Amgen as well as certain of Amgen’s top executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • ), the Amgen class action lawsuit charges Amgen as well as certain of Amgen’s top executives with violations of the Securities Exchange Act of 1934.
  • Lead plaintiff motions for the Amgen class action lawsuit must be filed with the court no later than May 12, 2023.
  • The lead plaintiff can select a law firm of its choice to litigate the Amgen class action lawsuit.
  • An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Amgen class action lawsuit.

AMGEN INC. (NASDAQ: AMGN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amgen Inc. (NASDAQ: AMGN)

Retrieved on: 
Monday, March 20, 2023

NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Amgen Inc. (“Amgen” or the “Company”) (NASDAQ: AMGN) between July 29, 2020 and April 27, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The Company boasts a large and varied patented drug portfolio, with numerous additional drug candidates under development.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

AMGN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Securities Class Action Lawsuit Against Amgen Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Lawsuit

Retrieved on: 
Saturday, March 18, 2023

), the Amgen class action lawsuit charges Amgen and certain of Amgen’s top executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • ), the Amgen class action lawsuit charges Amgen and certain of Amgen’s top executives with violations of the Securities Exchange Act of 1934.
  • Lead plaintiff motions for the Amgen class action lawsuit must be filed with the court no later than May 12, 2023.
  • The lead plaintiff can select a law firm of its choice to litigate the Amgen class action lawsuit.
  • An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Amgen class action lawsuit.